Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Procera Networks To Sell 3.5 Mln Shares

4/10/2012 4:08 PM ET

Procera Networks Inc. (PKT: Quote) Tuesday said it plans to sell 3.5 million shares in a public offering. Procera said it will use the proceeds for working capital and general corporate purposes including potential acquisitions.

Procera intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares to cover over-allotments, if any.

Stifel Nicolaus Weisel is the sole book-running manager, while William Blair & Company is the co-lead manager and Pacific Crest Securities, Raymond James and Sterne Agee are serving as co-managers.

Click here to receive FREE breaking news email alerts for Procera Networks Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks are turning in a lackluster performance in morning trading on Monday after showing a strong move to the upside last week. The major averages have been unable to sustain any significant moves, bouncing back and forth across the unchanged line. Leading U.S. economic indicators showed continued improvement in the month of March, according to a report released by the Conference Board on Monday, with the leading economic index rising by slightly more than expected. The Conference Board said its leading economic index rose by 0.8 percent in March after climbing by 0.5 percent in February. Healthcare products maker Kimberly-Clark Corp. (KMB) said that its first-quarter net income attributable to the company rose to $538 million from the prior year's $531 million, with earnings per share improving to $1.41 from $1.36 last year. Adjusted earnings for the quarter were $1.48 per share,...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.